Harmony Biosciences acquires US rights to Pitolisant from Bioprojet

Overview


A multinational McDermott team advised France’s Bioprojet as it sold US rights to market the drug Pitolisant. Emmanuelle Trombe, Charles de Raignac,Louise Aberg and Albert Sokol gave corporate advice, while Jeffrey Brennan, Jon Dubrow and Melanie Hallas advised on competition aspects.